Annelie Liljegren

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. doi request reprint Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial
    Annelie Liljegren
    Department of Oncology, Radiumhemmet, Karolinska University Hospital and Karolinska Institutet, 171 76 Stockholm, Sweden
    Breast Cancer Res Treat 135:791-8. 2012
  2. pmc Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
    Logan C Walker
    Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia
    Breast Cancer Res 12:R102. 2010
  3. doi request reprint Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer
    Annelie Liljegren
    Karolinska Institutet and Karolinska University Hospital, SE 171 76, Stockholm, Sweden
    Breast 18:259-62. 2009
  4. doi request reprint Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience
    Dmytro Unukovych
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Acta Oncol 51:934-41. 2012
  5. doi request reprint Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer
    Jonas Bergh
    Karolinska Institutet and University Hospital, Stockholm, Sweden
    Breast 21:507-13. 2012
  6. doi request reprint First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study
    Jonas Bergh
    Karolinska Institutet and University Hospital, 171 76 Stockholm, Sweden
    J Clin Oncol 30:921-9. 2012
  7. pmc Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
    Anne Kinhult Ståhlbom
    Department of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden
    Fam Cancer 11:33-40. 2012
  8. pmc No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction
    Annelie Liljegren
    Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Radiat Oncol 9:14. 2014
  9. doi request reprint Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study
    Dmytro Unukovych
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    World J Surg 36:695-701. 2012
  10. doi request reprint Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics
    Edoardo Colzani
    Department of Medical Epidemiology and Biostatistics MEB, Karolinska Institutet, Stockholm, Sweden
    J Clin Oncol 29:4014-21. 2011

Collaborators

  • Kerstin Sandelin
  • Dmytro Unukovych
  • Jonas Bergh
  • Anna von Wachenfeldt
  • Giovanna Gagliardi
  • Annika Lindblom
  • Arlene Chan
  • Javier Cortes
  • Alain Lortholary
  • Luca Gianni
  • Brita Arver
  • Gabriella Mariani
  • Anna L V Johansson
  • Edoardo Colzani
  • Kamila Czene
  • Ahmad Awada
  • Jan Adolfsson
  • Anne Kinhult Ståhlbom
  • Logan C Walker
  • Yvonne Brandberg
  • Hemming Johansson
  • Christian F Singer
  • Quinten Waisfisz
  • Katherine L Nathanson
  • Peter Devilee
  • Georgia Chenevix-Trench
  • Kai Ren Ong
  • Tuomas Heikkinen
  • Antonis C Antoniou
  • Margreet Gem Ausems
  • Bjarni A Agnarsson
  • Ulf Kristoffersson
  • Daniele Muller
  • Cora M Aalfs
  • Amanda B Spurdle
  • Sophie Giraud
  • Ines Schönbuchner
  • Frans B Hogervorst
  • Georg Pfeiler
  • Barbara Wappenschmidt
  • Patricia Harrington
  • Ans Mw Van den Ouweland
  • Lesley McGuffog
  • Rita K Schmutzler
  • Hakan Olsson
  • Fiona Lalloo
  • Fergus J Couch
  • Per Karlsson
  • Jonathan Beesley
  • Olga M Sinilnikova
  • Tim Rebbeck
  • Monique M Gerrits
  • Xiaoqing Chen
  • Beatrice Melin
  • Christi J van Asperen
  • Heli Nevanlinna
  • Jean Pierre Fricker
  • Robert Tarrell
  • Csilla I Szabo
  • Sylvie Mazoyer
  • Martijn Verheus
  • Susan M Domchek
  • Vernon S Pankratz
  • Debra Frost
  • Anne Catharina Dressler
  • Capucine Delnatte
  • Marcel R Nelen
  • Carol Chu
  • Xianshu Wang
  • Rosemarie Davidson
  • Andrew K Godwin
  • Maartje J Hooning
  • Noralane M Lindor
  • Carole Tirapo
  • Daphne Gschwantler-Kaulich
  • Susan Peock
  • Margaret Cook
  • Diana Eccles
  • Maria Adelaide Caligo
  • Ros Eeles
  • Clare T Oliver
  • Jackie Cook
  • D Gareth Evans
  • Christoph Engel
  • Louise Izatt
  • Sue Healey
  • Zachary S Fredericksen
  • Dominique Stoppa-Lyonnet
  • Helmut Deissler
  • Alfons Meindl

Detail Information

Publications11

  1. doi request reprint Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial
    Annelie Liljegren
    Department of Oncology, Radiumhemmet, Karolinska University Hospital and Karolinska Institutet, 171 76 Stockholm, Sweden
    Breast Cancer Res Treat 135:791-8. 2012
    ..Our study shows that both true and CTRL reduce vasomotor symptoms in breast cancer patients treated with adjuvant tamoxifen...
  2. pmc Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
    Logan C Walker
    Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia
    Breast Cancer Res 12:R102. 2010
    ..In this study, we evaluated 24 SNPs tagged to 14 candidate genes derived through a novel approach that analysed gene expression differences to prioritise candidate modifier genes for association studies...
  3. doi request reprint Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer
    Annelie Liljegren
    Karolinska Institutet and Karolinska University Hospital, SE 171 76, Stockholm, Sweden
    Breast 18:259-62. 2009
    ..The current report describes four patients with advanced/metastatic breast cancer who experienced clinically meaningful responses following treatment with sunitinib in combination with docetaxel...
  4. doi request reprint Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience
    Dmytro Unukovych
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Acta Oncol 51:934-41. 2012
    ....
  5. doi request reprint Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer
    Jonas Bergh
    Karolinska Institutet and University Hospital, Stockholm, Sweden
    Breast 21:507-13. 2012
    ..This exploratory study examined the pharmacokinetics, safety, and antitumor activity of sunitinib plus docetaxel in patients with HER-2-negative advanced breast cancer...
  6. doi request reprint First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study
    Jonas Bergh
    Karolinska Institutet and University Hospital, 171 76 Stockholm, Sweden
    J Clin Oncol 30:921-9. 2012
    ..To investigate whether sunitinib plus docetaxel improves clinical outcomes for patients with human epidermal growth factor receptor 2 (HER2)/neu-negative advanced breast cancer (ABC) versus docetaxel alone...
  7. pmc Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
    Anne Kinhult Ståhlbom
    Department of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden
    Fam Cancer 11:33-40. 2012
    ..Application of local mutation frequencies of BRCA1 and BRCA2 could improve the ability to distinguish between the two genes...
  8. pmc No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction
    Annelie Liljegren
    Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
    Radiat Oncol 9:14. 2014
    ..In the current study, the presence of breast implants during postmastectomy radiotherapy was not associated with increased doses to ipsilateral lung and heart, but CTV definition and its dosimetric characteristics urge further evaluation...
  9. doi request reprint Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study
    Dmytro Unukovych
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    World J Surg 36:695-701. 2012
    ..Since it is prohibited in most countries, PAAG injections are rare nowadays, but their consequences and long-term complications can be crucial...
  10. doi request reprint Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics
    Edoardo Colzani
    Department of Medical Epidemiology and Biostatistics MEB, Karolinska Institutet, Stockholm, Sweden
    J Clin Oncol 29:4014-21. 2011
    ..Because breast cancer-specific deaths decrease with time since diagnosis, it is important to assess the burden of other causes of death in women diagnosed with breast cancer...
  11. ncbi request reprint Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study
    Yvonne Brandberg
    Department of Oncology Pathology, Karolinska Institutet, Radiumhemmet, Karolinska University Hospital, S 171 76, Stockholm, Sweden
    J Clin Oncol 26:3943-9. 2008
    ....